Shares of Haleon plc (NYSE:HLN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $10.95.
Several analysts have recently commented on HLN shares. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th.
View Our Latest Research Report on HLN
Haleon Trading Up 0.4 %
Hedge Funds Weigh In On Haleon
Institutional investors and hedge funds have recently bought and sold shares of the stock. Procyon Advisors LLC grew its stake in Haleon by 41.3% during the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after buying an additional 67,329 shares during the period. HighTower Advisors LLC lifted its stake in shares of Haleon by 27.2% during the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock worth $3,701,000 after purchasing an additional 74,970 shares in the last quarter. Jane Street Group LLC boosted its position in shares of Haleon by 1,689.4% in the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock worth $2,803,000 after buying an additional 250,169 shares during the period. Chartwell Investment Partners LLC grew its stake in shares of Haleon by 107.8% in the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after buying an additional 246,594 shares in the last quarter. Finally, Townsquare Capital LLC raised its holdings in shares of Haleon by 29.8% during the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after buying an additional 109,217 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Articles
- Five stocks we like better than Haleon
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- The Risks of Owning Bonds
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- With Risk Tolerance, One Size Does Not Fit All
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.